表紙:感染管理サーベイランスソリューション市場:コンポーネント別、エンドユーザー別規模、産業分析レポート、成長性、価格動向、競合市場シェアと予測、2022年~2030年
市場調査レポート
商品コード
1119569

感染管理サーベイランスソリューション市場:コンポーネント別、エンドユーザー別規模、産業分析レポート、成長性、価格動向、競合市場シェアと予測、2022年~2030年

Infection Control Surveillance Solutions Market Size By Component, By End-user, Industry Analysis Report, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2022 - 2030.

出版日: | 発行: Global Market Insights Inc. | ページ情報: 英文 240 Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
感染管理サーベイランスソリューション市場:コンポーネント別、エンドユーザー別規模、産業分析レポート、成長性、価格動向、競合市場シェアと予測、2022年~2030年
出版日: 2022年08月23日
発行: Global Market Insights Inc.
ページ情報: 英文 240 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の感染管理サーベイランスソリューションの市場規模は、高齢者人口の増加やヘルスケア関連感染の発生率の上昇を背景に、2030年までにかなりの拡大を遂げると見込まれています。

研究によると、高齢者は心血管疾患、認知症、骨粗しょう症などの慢性疾患にかかりやすくなることが示唆されています。これらの疾患の診断と治療には、重要な医療処置と頻繁な病院受診が必要となり、HAIの蔓延を招き、感染管理サーベイランスソフトウェアの需要を押し上げています。

当レポートでは、世界の感染管理サーベイランスソリューション市場について調査し、市場の概要とともに、コンポーネント別、エンドユーザー別、地域別動向、および市場に参入する企業の競合動向などを提供しています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 感染管理サーベイランスソリューション業界考察

  • 業界セグメンテーション
  • 業界情勢、2017年~2030年
  • 業界への影響要因
  • 成長性分析
  • COVID-19の影響分析
  • ポーターの分析
  • 競合情勢、2021年
  • PESTEL分析

第4章 感染管理サーベイランスソリューション市場、コンポーネント別

  • 主要セグメントの動向
  • ソフトウェア
  • サービス

第5章 感染管理サーベイランスソリューション市場、エンドユーザー別

  • 主要セグメントの動向
  • 病院
  • 診療所
  • 外来手術センター
  • 専門センター

第6章 感染管理サーベイランスソリューション市場、地域別

  • 主な地域動向
  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • 中東・アフリカ

第7章 企業プロファイル

  • Competitive dashboard, 2021
  • Oracle(Cerner Corporation)
  • Baxter International Inc.
  • Becton, Dickinson and Company(BD)
  • Premier(TheraDoc)
  • Harris Healthcare.
  • Epic Systems Corporation
  • Asolva Inc
  • International Business Machines Corporation(IBM)
  • Ecolab
  • Wolters Kluwer N.V
  • Halma plc.(Centrak)
  • Roper Technologies
  • PeraHealth
  • VigiLanz
  • Vecna Technologies, Inc.
  • BioVigil Healthcare Systems, Inc.
図表

Data Tables

  • TABLE 1. Global infection control surveillance solutions market, 2017 - 2021 (USD Million)
  • TABLE 2. Global infection control surveillance solutions market, 2022 - 2030 (USD Million)
  • TABLE 3. Global infection control surveillance solutions market, by component, 2017 - 2021 (USD Million)
  • TABLE 4. Global infection control surveillance solutions market, by component, 2022 - 2030 (USD Million)
  • TABLE 5. Global infection control surveillance solutions market, by end-user, 2017 - 2021 (USD Million)
  • TABLE 6. Global infection control surveillance solutions market, by end-user, 2022 - 2030 (USD Million)
  • TABLE 7. Global infection control surveillance solutions market, by region, 2017 - 2021 (USD Million)
  • TABLE 8. Global infection control surveillance solutions market, by region, 2022 - 2030 (USD Million)
  • TABLE 9. Industry impact forces
  • TABLE 10. Software market, by region, 2017 - 2021, (USD Million)
  • TABLE 11. Software market, by region, 2022 - 2030, (USD Million)
  • TABLE 12. On-premise market, by region, 2017 - 2021, (USD Million)
  • TABLE 13. On-premise market, by region, 2022 - 2030, (USD Million)
  • TABLE 14. Web-based market, by region, 2017 - 2021, (USD Million)
  • TABLE 15. Web-based market, by region, 2022 - 2030, (USD Million)
  • TABLE 16. Services market, by region, 2017 - 2021, (USD Million)
  • TABLE 17. Services market, by region, 2022 - 2030, (USD Million)
  • TABLE 18. Hospitals market, by region, 2017 - 2021, (USD Million)
  • TABLE 19. Hospitals market, by region, 2022 - 2030, (USD Million)
  • TABLE 20. Clinics market, by region, 2017 - 2021, (USD Million)
  • TABLE 21. Clinics market, by region, 2022 - 2030, (USD Million)
  • TABLE 22. Ambulatory surgical centres market, by region, 2017 - 2021, (USD Million)
  • TABLE 23. Ambulatory surgical centres market, by region, 2022 - 2030, (USD Million)
  • TABLE 24. Specialty centres market, by region, 2017 - 2021, (USD Million)
  • TABLE 25. Specialty centres market, by region, 2022 - 2030, (USD Million)
  • TABLE 26. Others market, by region, 2017 - 2021, (USD Million)
  • TABLE 27. Others market, by region, 2022 - 2030, (USD Million)
  • TABLE 28. North America infection control surveillance solutions market, by country, 2017-2021, (USD Million)
  • TABLE 29. North America infection control surveillance solutions market, by country, 2022-2030, (USD Million)
  • TABLE 30. North America infection control surveillance solutions market, by component, 2017-2021, (USD Million)
  • TABLE 31. North America infection control surveillance solutions market, by component, 2022-2030, (USD Million)
  • TABLE 32. North America infection control surveillance solutions market, by software, 2017-2021, (USD Million)
  • TABLE 33. North America infection control surveillance solutions market, by software, 2022-2030, (USD Million)
  • TABLE 34. North America infection control surveillance solutions market, by end-user, 2017-2021, (USD Million)
  • TABLE 35. North America infection control surveillance solutions market, by end-user, 2022-2030, (USD Million)
  • TABLE 36. U.S. infection control surveillance solutions market, by component, 2017-2021, (USD Million)
  • TABLE 37. U.S. infection control surveillance solutions market, by component, 2022-2030, (USD Million)
  • TABLE 38. U.S. infection control surveillance solutions market, by software, 2017-2021, (USD Million)
  • TABLE 39. U.S. infection control surveillance solutions market, by software, 2022-2030, (USD Million)
  • TABLE 40. U.S. infection control surveillance solutions market, by end-user, 2017-2021, (USD Million)
  • TABLE 41. U.S. infection control surveillance solutions market, by end-user, 2022-2030, (USD Million)
  • TABLE 42. Canada infection control surveillance solutions market, by component, 2017-2021, (USD Million)
  • TABLE 43. Canada infection control surveillance solutions market, by component, 2022-2030, (USD Million)
  • TABLE 44. Canada infection control surveillance solutions market, by software, 2017-2021, (USD Million)
  • TABLE 45. Canada infection control surveillance solutions market, by software, 2022-2030, (USD Million)
  • TABLE 46. Canada infection control surveillance solutions market, by end-user, 2017-2021, (USD Million)
  • TABLE 47. Canada infection control surveillance solutions market, by end-user, 2022-2030, (USD Million)
  • TABLE 48. Europe infection control surveillance solutions market, by country, 2017-2021, (USD Million)
  • TABLE 49. Europe infection control surveillance solutions market, by country, 2022-2030, (USD Million)
  • TABLE 50. Europe infection control surveillance solutions market, by component, 2017-2021, (USD Million)
  • TABLE 51. Europe infection control surveillance solutions market, by component, 2022-2030, (USD Million)
  • TABLE 52. Europe infection control surveillance solutions market, by software, 2017-2021, (USD Million)
  • TABLE 53. Europe infection control surveillance solutions market, by software, 2022-2030, (USD Million)
  • TABLE 54. Europe infection control surveillance solutions market, by end-user, 2017-2021, (USD Million)
  • TABLE 55. Europe infection control surveillance solutions market, by end-user, 2022-2030, (USD Million)
  • TABLE 56. Germany infection control surveillance solutions market, by component, 2017-2021, (USD Million)
  • TABLE 57. Germany infection control surveillance solutions market, by component, 2022-2030, (USD Million)
  • TABLE 58. Germany infection control surveillance solutions market, by software, 2017-2021, (USD Million)
  • TABLE 59. Germany infection control surveillance solutions market, by software, 2022-2030, (USD Million)
  • TABLE 60. Germany infection control surveillance solutions market, by end-user, 2017-2021, (USD Million)
  • TABLE 61. Germany infection control surveillance solutions market, by end-user, 2022-2030, (USD Million)
  • TABLE 62. UK infection control surveillance solutions market, by component, 2017-2021, (USD Million)
  • TABLE 63. UK infection control surveillance solutions market, by component, 2022-2030, (USD Million)
  • TABLE 64. UK infection control surveillance solutions market, by software, 2017-2021, (USD Million)
  • TABLE 65. UK infection control surveillance solutions market, by software, 2022-2030, (USD Million)
  • TABLE 66. UK infection control surveillance solutions market, by end-user, 2017-2021, (USD Million)
  • TABLE 67. UK infection control surveillance solutions market, by end-user, 2022-2030, (USD Million)
  • TABLE 68. France infection control surveillance solutions market, by component, 2017-2021, (USD Million)
  • TABLE 69. France infection control surveillance solutions market, by component, 2022-2030, (USD Million)
  • TABLE 70. France infection control surveillance solutions market, by end-user, 2017-2021, (USD Million)
  • TABLE 71. France infection control surveillance solutions market, by end-user, 2022-2030, (USD Million)
  • TABLE 72. Italy infection control surveillance solutions market, by component, 2017-2021, (USD Million)
  • TABLE 73. Italy infection control surveillance solutions market, by component, 2022-2030, (USD Million)
  • TABLE 74. Italy infection control surveillance solutions market, by software, 2017-2021, (USD Million)
  • TABLE 75. Italy infection control surveillance solutions market, by software, 2022-2030, (USD Million)
  • TABLE 76. Italy infection control surveillance solutions market, by end-user, 2017-2021, (USD Million)
  • TABLE 77. Italy infection control surveillance solutions market, by end-user, 2022-2030, (USD Million)
  • TABLE 78. Spain infection control surveillance solutions market, by component, 2017-2021, (USD Million)
  • TABLE 79. Spain infection control surveillance solutions market, by component, 2022-2030, (USD Million)
  • TABLE 80. Spain infection control surveillance solutions market, by software, 2017-2021, (USD Million)
  • TABLE 81. Spain infection control surveillance solutions market, by software, 2022-2030, (USD Million)
  • TABLE 82. Spain infection control surveillance solutions market, by end-user, 2017-2021, (USD Million)
  • TABLE 83. Spain infection control surveillance solutions market, by end-user, 2022-2030, (USD Million)
  • TABLE 84. Asia Pacific infection control surveillance solutions market, by country, 2017-2021, (USD Million)
  • TABLE 85. Asia Pacific infection control surveillance solutions market, by country, 2022-2030, (USD Million)
  • TABLE 86. Asia Pacific infection control surveillance solutions market, by component, 2017-2021, (USD Million)
  • TABLE 87. Asia Pacific infection control surveillance solutions market, by component, 2022-2030, (USD Million)
  • TABLE 88. Asia Pacific infection control surveillance solutions market, by software, 2017-2021, (USD Million)
  • TABLE 89. Asia Pacific infection control surveillance solutions market, by software, 2022-2030, (USD Million)
  • TABLE 90. Asia Pacific infection control surveillance solutions market, by end-user, 2017-2021, (USD Million)
  • TABLE 91. Asia Pacific infection control surveillance solutions market, by end-user, 2022-2030, (USD Million)
  • TABLE 92. Japan infection control surveillance solutions market, by component, 2017-2021, (USD Million)
  • TABLE 93. Japan infection control surveillance solutions market, by component, 2022-2030, (USD Million)
  • TABLE 94. Japan infection control surveillance solutions market, by software, 2017-2021, (USD Million)
  • TABLE 95. Japan infection control surveillance solutions market, by software, 2022-2030, (USD Million)
  • TABLE 96. Japan infection control surveillance solutions market, by end-user, 2017-2021, (USD Million)
  • TABLE 97. Japan infection control surveillance solutions market, by end-user, 2022-2030, (USD Million)
  • TABLE 98. China infection control surveillance solutions market, by component, 2017-2021, (USD Million)
  • TABLE 99. China infection control surveillance solutions market, by component, 2022-2030, (USD Million)
  • TABLE 100. China infection control surveillance solutions market, by software, 2017-2021, (USD Million)
  • TABLE 101. China infection control surveillance solutions market, by software, 2022-2030, (USD Million)
  • TABLE 102. China infection control surveillance solutions market, by end-user, 2017-2021, (USD Million)
  • TABLE 103. China infection control surveillance solutions market, by end-user, 2022-2030, (USD Million)
  • TABLE 104. India infection control surveillance solutions market, by component, 2017-2021, (USD Million)
  • TABLE 105. India infection control surveillance solutions market, by component, 2022-2030, (USD Million)
  • TABLE 106. India infection control surveillance solutions market, by software, 2017-2021, (USD Million)
  • TABLE 107. India infection control surveillance solutions market, by software, 2022-2030, (USD Million)
  • TABLE 108. India infection control surveillance solutions market, by end-user, 2017-2021, (USD Million)
  • TABLE 109. India infection control surveillance solutions market, by end-user, 2022-2030, (USD Million)
  • TABLE 110. Australia infection control surveillance solutions market, by component, 2017-2021, (USD Million)
  • TABLE 111. Australia infection control surveillance solutions market, by component, 2022-2030, (USD Million)
  • TABLE 112. Australia infection control surveillance solutions market, by software, 2017-2021, (USD Million)
  • TABLE 113. Australia infection control surveillance solutions market, by software, 2022-2030, (USD Million)
  • TABLE 114. Australia infection control surveillance solutions market, by end-user, 2017-2021, (USD Million)
  • TABLE 115. Australia infection control surveillance solutions market, by end-user, 2022-2030, (USD Million)
  • TABLE 116. Latin America infection control surveillance solutions market, by country, 2017-2021, (USD Million)
  • TABLE 117. Latin America infection control surveillance solutions market, by country, 2022-2030, (USD Million)
  • TABLE 118. Latin America infection control surveillance solutions market, by component, 2017-2021, (USD Million)
  • TABLE 119. Latin America infection control surveillance solutions market, by component, 2022-2030, (USD Million)
  • TABLE 120. Latin America infection control surveillance solutions market, by software, 2017-2021, (USD Million)
  • TABLE 121. Latin America infection control surveillance solutions market, by software, 2022-2030, (USD Million)
  • TABLE 122. Latin America infection control surveillance solutions market, by end-user, 2017-2021, (USD Million)
  • TABLE 123. Latin America infection control surveillance solutions market, by end-user, 2022-2030, (USD Million)
  • TABLE 124. Brazil infection control surveillance solutions market, by component, 2017-2021, (USD Million)
  • TABLE 125. Brazil infection control surveillance solutions market, by component, 2022-2030, (USD Million)
  • TABLE 126. Brazil infection control surveillance solutions market, by software, 2017-2021, (USD Million)
  • TABLE 127. Brazil infection control surveillance solutions market, by software, 2022-2030, (USD Million)
  • TABLE 128. Brazil infection control surveillance solutions market, by end-user, 2017-2021, (USD Million)
  • TABLE 129. Brazil infection control surveillance solutions market, by end-user, 2022-2030, (USD Million)
  • TABLE 130. Mexico infection control surveillance solutions market, by component, 2017-2021, (USD Million)
  • TABLE 131. Mexico infection control surveillance solutions market, by component, 2022-2030, (USD Million)
  • TABLE 132. Mexico infection control surveillance solutions market, by software, 2017-2021, (USD Million)
  • TABLE 133. Mexico infection control surveillance solutions market, by software, 2022-2030, (USD Million)
  • TABLE 134. Mexico infection control surveillance solutions market, by end-user, 2017-2021, (USD Million)
  • TABLE 135. Mexico infection control surveillance solutions market, by end-user, 2022-2030, (USD Million)
  • TABLE 136. Argentina infection control surveillance solutions market, by component, 2017-2021, (USD Million)
  • TABLE 137. Argentina infection control surveillance solutions market, by component, 2022-2030, (USD Million)
  • TABLE 138. Argentina infection control surveillance solutions market, by software, 2017-2021, (USD Million)
  • TABLE 139. Argentina infection control surveillance solutions market, by software, 2022-2030, (USD Million)
  • TABLE 140. Argentina infection control surveillance solutions market, by end-user, 2017-2021, (USD Million)
  • TABLE 141. Argentina infection control surveillance solutions market, by end-user, 2022-2030, (USD Million)
  • TABLE 142. MEA infection control surveillance solutions market, by country, 2017-2021, (USD Million)
  • TABLE 143. MEA infection control surveillance solutions market, by country, 2022-2030, (USD Million)
  • TABLE 144. MEA infection control surveillance solutions market, by component, 2017-2021, (USD Million)
  • TABLE 145. MEA infection control surveillance solutions market, by component, 2022-2030, (USD Million)
  • TABLE 146. MEA infection control surveillance solutions market, by software, 2017-2021, (USD Million)
  • TABLE 147. MEA infection control surveillance solutions market, by software, 2022-2030, (USD Million)
  • TABLE 148. MEA infection control surveillance solutions market, by end-user, 2017-2021, (USD Million)
  • TABLE 149. MEA infection control surveillance solutions market, by end-user, 2022-2030, (USD Million)
  • TABLE 150. South Africa infection control surveillance solutions market, by component, 2017-2021, (USD Million)
  • TABLE 151. South Africa infection control surveillance solutions market, by component, 2022-2030, (USD Million)
  • TABLE 152. South Africa infection control surveillance solutions market, by software, 2017-2021, (USD Million)
  • TABLE 153. South Africa infection control surveillance solutions market, by software, 2022-2030, (USD Million)
  • TABLE 154. South Africa infection control surveillance solutions market, by end-user, 2017-2021, (USD Million)
  • TABLE 155. South Africa infection control surveillance solutions market, by end-user, 2022-2030, (USD Million)
  • TABLE 156. Saudi Arabia infection control surveillance solutions market, by component, 2017-2021, (USD Million)
  • TABLE 157. Saudi Arabia infection control surveillance solutions market, by component, 2022-2030, (USD Million)
  • TABLE 158. Saudi Arabia infection control surveillance solutions market, by software, 2017-2021, (USD Million)
  • TABLE 159. Saudi Arabia infection control surveillance solutions market, by software, 2022-2030, (USD Million)
  • TABLE 160. Saudi Arabia infection control surveillance solutions market, by end-user, 2017-2021, (USD Million)
  • TABLE 161. Saudi Arabia infection control surveillance solutions market, by end-user, 2022-2030, (USD Million)
  • TABLE 162. UAE infection control surveillance solutions market, by component, 2017-2021, (USD Million)
  • TABLE 163. UAE infection control surveillance solutions market, by component, 2022-2030, (USD Million)
  • TABLE 164. UAE infection control surveillance solutions market, by software, 2017-2021, (USD Million)
  • TABLE 165. UAE infection control surveillance solutions market, by software, 2022-2030, (USD Million)
  • TABLE 166. UAE infection control surveillance solutions market, by end-user, 2017-2021, (USD Million)
  • TABLE 167. UAE infection control surveillance solutions market, by end-user, 2022-2030, (USD Million)

Charts & Figures

  • FIG 1. Top-down approach
  • FIG 2 Bottom-up approach
  • FIG 3. Breakdown of primary participants
  • FIG 4. Infection control surveillance solutions industry 360 degree synopsis, 2017 - 2030
  • FIG 5. Industry segmentation
  • FIG 6. Industry landscape, 2017-2030 (USD Million)
  • FIG 7. Growth potential analysis, by component
  • FIG 8. Growth potential analysis, by end-user
  • FIG 9. Company matrix analysis, 2021
  • FIG 10. Porter's analysis
  • FIG 11. PESTEL analysis
  • FIG 12. Key segment trends, by component
  • FIG 13. Key segment trends, by end-user
  • FIG 14. Key regional trends
  • FIG 15. Strategy dashboard, 2021
目次
Product Code: 5312

The global infection control surveillance solutions market is poised to hold a sizeable valuation by 2030, driven by the increasing geriatric population and rising incidences of healthcare-acquired infections. According to the UN World population prospects, in 2019, around 703 million people across the globe were aged 65 years or over. These numbers are likely to increase by two folds to 1.5 billion in 2050.

Studies suggest that aging people show greater susceptibility to chronic disorders such as cardiovascular diseases, dementia, osteoporosis, etc. The diagnosis and treatment of these diseases require critical medical care and frequent hospital visits leading to the growing prevalence of HAIs and boosting the demand for infection control surveillance software.

Based on components, the infection control surveillance services market is expected to depict an appreciable growth rate over the forecast period. The increasing number of surgical interventions and the rapidly growing incidences of infectious and chronic health disorders among the geriatric population have emerged as leading factors contributing to the segmental expansion.

Compelled by the growing disease prevalence, governments, and associated authorities across several economies have been making huge investments to support the development of efficient infection surveillance services, thus streamlining the industry expansion.

For instance, in June 2022, the European Centre for Disease Prevention and Control (ECDC) announced the launch of EpiPulse- the European surveillance portal for infectious diseases. The service integrates several previously independent surveillance systems and offers new functionalities and seamless access to data in a single platform.

With respect to end-use, specialty centers are likely to gain appreciable momentum, with the estimated valuation expected to surpass USD 67 million by 2030. Specialty centers are healthcare establishments equipped to offer efficient, focused, and high-quality care. The primary factor backing the segment growth is the rapid expansion of the healthcare infrastructure globally due to the escalating public and private investments, driven by the emergence of contagious diseases like COVID-19 and monkeypox.

These public health emergencies require specialized medical care. The availability of emergency and acute care and a staff capable of treating patients with all health disorders will push the adoption of infection control surveillance solutions across specialty centers.

Regionally, Latin America (LATAM) infection control surveillance solution market is speculated to exhibit over 13% CAGR over the forecast period and may account for considerable revenue by 2030. The expansion of the regional industry can be attributed to the positive outlook of medical tourism and the presence of a massive population base.

Based on the latest UN estimations, as of August 23, 2021, the population of Latin America and The Caribbean stands at more than 660 million, accounting for over 8% of the total world population. The emergence of several health hazards associated with population growth, including poor vector control, sanitation, food, water contamination, etc., may lead to increased disease burden, strengthening the infection control surveillance market outlook.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Methodology
  • 1.2 Base estimates and working
    • 1.2.1 North America
    • 1.2.2 Europe
    • 1.2.3 Asia Pacific
    • 1.2.4 Latin America
    • 1.2.5 MEA
  • 1.3 Forecast parameters
  • 1.4 Data validation
  • 1.5 Data sources
    • 1.5.1 Secondary
      • 1.5.1.1 Paid sources
      • 1.5.1.2 Public sources
    • 1.5.2 Primary

Chapter 2 Executive Summary

  • 2.1 Infection control surveillance solutions industry 360 degree synopsis, 2017 - 2030
    • 2.1.1 Business trends
    • 2.1.2 Component trends
    • 2.1.3 End-user trends
    • 2.1.4 Regional trends

Chapter 3 Infection Control Surveillance Solutions Industry Insights

  • 3.1 Industry segmentation
  • 3.2 Industry landscape, 2017 - 2030
  • 3.3 Industry impact forces
    • 3.3.1 Growth drivers
      • 3.3.1.1 Surge in the number of nosocomial infections
      • 3.3.1.2 Rising technological advancements in the healthcare IT infrastructure
      • 3.3.1.3 Growing prevalence of infectious and chronic diseases
    • 3.3.2 Industry pitfalls & challenges
      • 3.3.2.1 Unwillingness among healthcare professionals to adopt innovative healthcare IT solutions
      • 3.3.2.2 Improper data management and lack of knowledge regarding IT among healthcare professionals
  • 3.4 Growth potential analysis
    • 3.4.1 By component
    • 3.4.2 By end-user
  • 3.5 COVID- 19 impact analysis
  • 3.6 Porter's analysis
    • 3.6.1 Bargaining power of suppliers
    • 3.6.2 Bargaining power of buyers
    • 3.6.3 Threat of new entrants
    • 3.6.4 Threat of substitutes
  • 3.7 Competitive landscape, 2021
    • 3.7.1 Company matrix analysis, 2021
  • 3.8 PESTEL analysis

Chapter 4 Infection Control Surveillance Solutions Market, By Component

  • 4.1 Key segment trends
  • 4.2 Software
    • 4.2.1 Market size, by region, 2017 - 2030 (USD Million)
    • 4.2.2 On-premise
      • 4.2.2.1 Market size, by region, 2017 - 2030 (USD Million)
    • 4.2.3 Web-based
      • 4.2.3.1 Market size, by region, 2017 - 2030 (USD Million)
  • 4.3 Services
    • 4.3.1 Market size, by region, 2017 - 2030 (USD Million)

Chapter 5 Infection Control Surveillance Solutions Market, By End-user

  • 5.1 Key segment trends
  • 5.2 Hospitals
    • 5.2.1 Market size, by region, 2017 - 2030 (USD Million)
  • 5.3 Clinics
    • 5.3.1 Market size, by region, 2017 - 2030 (USD Million)
  • 5.4 Ambulatory surgical centers
    • 5.4.1 Market size, by region, 2017 - 2030 (USD Million)
  • 5.5 Specialty centers
    • 5.5.1 Market size, by region, 2017 - 2030 (USD Million)
  • 5.6 Others
    • 5.6.1 Market size, by region, 2017 - 2030 (USD Million)

Chapter 6 Infection Control Surveillance Solutions Market, By Region

  • 6.1 Key regional trends
  • 6.2 North America
    • 6.2.1 Market size, by country, 2017 - 2030 (USD Million)
    • 6.2.2 Market size, by component, 2017 - 2030 (USD Million)
      • 6.2.2.1 Market size, by software, 2017 - 2030 (USD Million)
    • 6.2.3 Market size, by end-user, 2017 - 2030 (USD Million)
    • 6.2.4 U.S.
      • 6.2.4.1 Market size, by component, 2017 - 2030 (USD Million)
        • 6.2.4.1.1 Market size, by software, 2017 - 2030 (USD Million)
      • 6.2.4.2 Market size, by end-user, 2017 - 2030 (USD Million)
    • 6.2.5 Canada
      • 6.2.5.1 Market size, by component, 2017 - 2030 (USD Million)
        • 6.2.5.1.1 Market size, by software, 2017 - 2030 (USD Million)
      • 6.2.5.2 Market size, by end-user, 2017 - 2030 (USD Million)
  • 6.3 Europe
    • 6.3.1 Market size, by country, 2017 - 2030 (USD Million)
    • 6.3.2 Market size, by component, 2017 - 2030 (USD Million)
      • 6.3.2.1 Market size, by software, 2017 - 2030 (USD Million)
    • 6.3.3 Market size, by end-user, 2017 - 2030 (USD Million)
    • 6.3.4 Germany
      • 6.3.4.1 Market size, by component, 2017 - 2030 (USD Million)
        • 6.3.4.1.1 Market size, by software, 2017 - 2030 (USD Million)
      • 6.3.4.2 Market size, by end-user, 2017 - 2030 (USD Million)
    • 6.3.5 UK
      • 6.3.5.1 Market size, by component, 2017 - 2030 (USD Million)
        • 6.3.5.1.1 Market size, by software, 2017 - 2030 (USD Million)
      • 6.3.5.2 Market size, by end-user, 2017 - 2030 (USD Million)
    • 6.3.6 France
      • 6.3.6.1 Market size, by component, 2017 - 2030 (USD Million)
        • 6.3.6.1.1 Market size, by software, 2017 - 2030 (USD Million)
      • 6.3.6.2 Market size, by end-user, 2017 - 2030 (USD Million)
    • 6.3.7 Spain
      • 6.3.7.1 Market size, by component, 2017 - 2030 (USD Million)
        • 6.3.7.1.1 Market size, by software, 2017 - 2030 (USD Million)
      • 6.3.7.2 Market size, by end-user, 2017 - 2030 (USD Million)
    • 6.3.8 Italy
      • 6.3.8.1 Market size, by component, 2017 - 2030 (USD Million)
        • 6.3.8.1.1 Market size, by software, 2017 - 2030 (USD Million)
      • 6.3.8.2 Market size, by end-user, 2017 - 2030 (USD Million)
  • 6.4 Asia Pacific
    • 6.4.1 Market size, by country, 2017 - 2030 (USD Million)
    • 6.4.2 Market size, by component, 2017 - 2030 (USD Million)
      • 6.4.2.1 Market size, by software, 2017 - 2030 (USD Million)
    • 6.4.3 Market size, by end-user, 2017 - 2030 (USD Million)
    • 6.4.4 China
      • 6.4.4.1 Market size, by component, 2017 - 2030 (USD Million)
        • 6.4.4.1.1 Market size, by software, 2017 - 2030 (USD Million)
      • 6.4.4.2 Market size, by end-user, 2017 - 2030 (USD Million)
    • 6.4.5 Japan
      • 6.4.5.1 Market size, by component, 2017 - 2030 (USD Million)
        • 6.4.5.1.1 Market size, by software, 2017 - 2030 (USD Million)
      • 6.4.5.2 Market size, by end-user, 2017 - 2030 (USD Million)
    • 6.4.6 India
      • 6.4.6.1 Market size, by component, 2017 - 2030 (USD Million)
        • 6.4.6.1.1 Market size, by software, 2017 - 2030 (USD Million)
      • 6.4.6.2 Market size, by end-user, 2017 - 2030 (USD Million)
    • 6.4.7 South Korea
      • 6.4.7.1 Market size, by component, 2017 - 2030 (USD Million)
        • 6.4.7.1.1 Market size, by software, 2017 - 2030 (USD Million)
      • 6.4.7.2 Market size, by end-user, 2017 - 2030 (USD Million)
    • 6.4.8 Australia
      • 6.4.8.1 Market size, by component, 2017 - 2030 (USD Million)
        • 6.4.8.1.1 Market size, by software, 2017 - 2030 (USD Million)
      • 6.4.8.2 Market size, by end-user, 2017 - 2030 (USD Million)
  • 6.5 Latin America
    • 6.5.1 Market size, by country, 2017 - 2030 (USD Million)
    • 6.5.2 Market size, by component, 2017 - 2030 (USD Million)
      • 6.5.2.1 Market size, by software, 2017 - 2030 (USD Million)
    • 6.5.3 Market size, by end-user, 2017 - 2030 (USD Million)
    • 6.5.4 Brazil
      • 6.5.4.1 Market size, by component, 2017 - 2030 (USD Million)
        • 6.5.4.1.1 Market size, by software, 2017 - 2030 (USD Million)
      • 6.5.4.2 Market size, by end-user, 2017 - 2030 (USD Million)
    • 6.5.5 Mexico
      • 6.5.5.1 Market size, by component, 2017 - 2030 (USD Million)
        • 6.5.5.1.1 Market size, by software, 2017 - 2030 (USD Million)
      • 6.5.5.2 Market size, by end-user, 2017 - 2030 (USD Million)
    • 6.5.6 Argentina
      • 6.5.6.1 Market size, by component, 2017 - 2030 (USD Million)
        • 6.5.6.1.1 Market size, by software, 2017 - 2030 (USD Million)
      • 6.5.6.2 Market size, by end-user, 2017 - 2030 (USD Million)
  • 6.6 Middle East & Africa
    • 6.6.1 Market size, by country, 2017 - 2030 (USD Million)
    • 6.6.2 Market size, by component, 2017 - 2030 (USD Million)
      • 6.6.2.1 Market size, by software, 2017 - 2030 (USD Million)
    • 6.6.3 Market size, by end-user, 2017 - 2030 (USD Million)
    • 6.6.4 Saudi Arabia
      • 6.6.4.1 Market size, by component, 2017 - 2030 (USD Million)
        • 6.6.4.1.1 Market size, by software, 2017 - 2030 (USD Million)
      • 6.6.4.2 Market size, by end-user, 2017 - 2030 (USD Million)
    • 6.6.5 South Africa
      • 6.6.5.1 Market size, by component, 2017 - 2030 (USD Million)
        • 6.6.5.1.1 Market size, by software, 2017 - 2030 (USD Million)
      • 6.6.5.2 Market size, by end-user, 2017 - 2030 (USD Million)
    • 6.6.6 UAE
      • 6.6.6.1 Market size, by component, 2017 - 2030 (USD Million)
        • 6.6.6.1.1 Market size, by software, 2017 - 2030 (USD Million)
      • 6.6.6.2 Market size, by end-user, 2017 - 2030 (USD Million)

Chapter 7 Company Profiles

  • 7.1 Competitive dashboard, 2021
  • 7.2 Oracle (Cerner Corporation)
    • 7.2.1 Business overview
    • 7.2.2 Financial data
    • 7.2.3 Product landscape
    • 7.2.4 Strategic outlook
    • 7.2.5 SWOT analysis
  • 7.3 Baxter International Inc.
    • 7.3.1 Business overview
    • 7.3.2 Financial data
    • 7.3.3 Product landscape
    • 7.3.4 Strategic outlook
    • 7.3.5 SWOT analysis
  • 7.4 Becton, Dickinson and Company (BD)
    • 7.4.1 Business overview
    • 7.4.2 Financial data
    • 7.4.3 Product landscape
    • 7.4.4 Strategic outlook
    • 7.4.5 SWOT analysis
  • 7.5 Premier (TheraDoc)
    • 7.5.1 Business overview
    • 7.5.2 Financial data
    • 7.5.3 Product landscape
    • 7.5.4 Strategic outlook
    • 7.5.5 SWOT analysis
  • 7.6 Harris Healthcare.
    • 7.6.1 Business overview
    • 7.6.2 Financial data
    • 7.6.3 Product landscape
    • 7.6.4 Strategic outlook
    • 7.6.5 SWOT analysis
  • 7.7 Epic Systems Corporation
    • 7.7.1 Business overview
    • 7.7.2 Financial data
    • 7.7.3 Product landscape
    • 7.7.4 Strategic outlook
    • 7.7.5 SWOT analysis
  • 7.8 Asolva Inc
    • 7.8.1 Business overview
    • 7.8.2 Financial data
    • 7.8.3 Product landscape
    • 7.8.4 Strategic outlook
    • 7.8.5 SWOT analysis
  • 7.9 International Business Machines Corporation (IBM)
    • 7.9.1 Business overview
    • 7.9.2 Financial data
    • 7.9.3 Product landscape
    • 7.9.4 Strategic outlook
    • 7.9.5 SWOT analysis
  • 7.10 Ecolab
    • 7.10.1 Business overview
    • 7.10.2 Financial data
    • 7.10.3 Product landscape
    • 7.10.4 Strategic outlook
    • 7.10.5 SWOT analysis
  • 7.11 Wolters Kluwer N.V
    • 7.11.1 Business overview
    • 7.11.2 Financial data
    • 7.11.3 Product landscape
    • 7.11.4 Strategic outlook
    • 7.11.5 SWOT analysis
  • 7.12 Halma plc. (Centrak)
    • 7.12.1 Business overview
    • 7.12.2 Financial data
    • 7.12.3 Product landscape
    • 7.12.4 Strategic outlook
    • 7.12.5 SWOT analysis
  • 7.13 Roper Technologies
    • 7.13.1 Business overview
    • 7.13.2 Financial data
    • 7.13.3 Product landscape
    • 7.13.4 Strategic outlook
    • 7.13.5 SWOT analysis
  • 7.14 PeraHealth
    • 7.14.1 Business overview
    • 7.14.2 Financial data
    • 7.14.3 Product landscape
    • 7.14.4 Strategic outlook
    • 7.14.5 SWOT analysis
  • 7.15 VigiLanz
    • 7.15.1 Business overview
    • 7.15.2 Financial data
    • 7.15.3 Product landscape
    • 7.15.4 Strategic outlook
    • 7.15.5 SWOT analysis
  • 7.16 Vecna Technologies, Inc.
    • 7.16.1 Business overview
    • 7.16.2 Financial data
    • 7.16.3 Product landscape
    • 7.16.4 Strategic outlook
    • 7.16.5 SWOT analysis
  • 7.17 BioVigil Healthcare Systems, Inc.
    • 7.17.1 Business overview
    • 7.17.2 Financial data
    • 7.17.3 Product landscape
    • 7.17.4 Strategic outlook
    • 7.17.5 SWOT analysis